Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.4 was added, indicating a software version update in the page footer. This update does not modify the study content or visible functionality.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThis change updates the ClinicalTrials.gov page’s UI/release revision marker from v3.5.2 to v3.5.3 without altering the displayed study details.SummaryDifference0.1%

- Check42 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No study content or user-facing information appears to have changed.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the revision history.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision tag updated to v3.4.3. The previous v3.4.2 tag was removed.SummaryDifference0.1%

- Check106 days agoChange DetectedAdded Revision: v3.4.2; Deleted older notice about funding/operation status (Revision: v3.4.1). These are administrative updates that do not affect trial content or how users interact with the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.